Transcatheter Aortic Valve Replacement (TAVR) Effects on Cardiac Conduction System (TAVR-HBE)

  • End date
    May 18, 2024
  • participants needed
  • sponsor
    Beth Israel Deaconess Medical Center
Updated on 4 October 2022
aortic valve replacement
conduction disorders


This is a prospective observational study, the purpose of which is to:

  1. Characterize response of the AV conduction system to TAVR with various prostheses by recording continuous His bundle electrograms during valve placement.
  2. Correlate preprocedure ECG features with changes in AV nodal and infranodal conduction during placement of the valve prosthesis.
  3. Correlate changes in AV nodal and infranodal conduction during the procedure with risk of developing AV conduction block after TAVR.
  4. Assess the contribution of stressing the conduction system by atrial pacing prior to and following TAVR to prediction of postprocedural heart block.

Assess the correlation between new onset bundle branch block, site and degree of conduction block or delay and subsequent development of high-grade or complete AV block.


Study Population:

Inclusion criteria -all patients undergoing elective TAVR Exclusion criteria -patients with permanent implanted pacemakers or ICDs prior to TAVR

  1. Record standard 12-lead ECG prior to procedure.
  2. Place standard electrode catheter via a venous sheath prior to TAVR
  3. Initially place the catheter in a proximal position with a large atrial electrogram and proximal His electrogram.
  4. Record baseline His bundle electrogram. Record baseline AH and HV intervals.
  5. Pace the atrium starting at a cycle length 100 ms shorter than the sinus cycle length, progressively reducing the paced cycle length in 20 ms decrements after 3 seconds pacing at each cycle length, while continuously monitoring arterial blood pressure, to A-V block.
  6. Advance the distal electrodes while maintaining recording of a His bundle electrogram to a position where stable right ventricular pacing is secured. Record the RV pacing threshold.
  7. If a stable right ventricular pacing position together with stable His bundle electrogram cannot be achieved, a second venous temporary pacing wire will be placed.
  8. Record presence or absence of retrograde conduction during RV pacing at 4 times pacing threshold.
  9. Ensure stable continuous His bundle electrogram recording while the aortic valve prosthesis is deployed.
  10. Use the distal electrodes for rapid ventricular pacing at 4 times threshold during deployment of the valve prosthesis.
  11. After the prosthesis has been deployed and is deemed stable, just prior to removing the RV catheter, record a final HBE (AH, HBE, SCL) and again pull back catheter to enable atrial capture with proximal electrodes - pace as above to AV block: start starting at a cycle length 100 ms shorter than the sinus cycle length, progressively reducing the paced cycle length in 20 ms decrements after 3 seconds pacing at each cycle length while monitoring continuous arterial blood pressure to A-V block.
  12. Record 12-lead ECG after completion of the procedure and daily thereafter until hospital discharge.
  13. Standard telemetry monitoring post procedure while hospitalized.
  14. Upon hospital discharge place a standard continuous ambulatory ECG monitor for 2 weeks in patients that do not have a pacemaker implanted.

Condition Aortic Stenosis, Transcatheter Aortic Valve Replacement, Heart Block
Treatment Transcatheter aortic valve replacement
Clinical Study IdentifierNCT04982406
SponsorBeth Israel Deaconess Medical Center
Last Modified on4 October 2022


Yes No Not Sure

Inclusion Criteria

patients undergoing elective TAVR at BIDMC

Exclusion Criteria

patients with permanent implanted pacemakers or ICDs prior to TA
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note